Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Sclerostin inhibition in rare bone diseases: Molecular understanding and therapeutic perspectives

Published:2024-07 Issue: Volume:47 Page:39-49
ISSN:2214-031X
Container-title:Journal of Orthopaedic Translation
language:en
Short-container-title:Journal of Orthopaedic Translation

Author:

Xiaohui Tao,Wang Luyao,Yang Xin^ORCID,Jiang Hewen,Zhang Ning,Zhang Huarui,Li Dijie,Li Xiaofei,Zhang Yihao,Wang Shenghang,Zhong Chuanxin,Yu Sifan,Ren Meishen,Sun Meiheng,Li Nanxi,Chen Tienan,Ma Yuan,Li Fangfei,Liu Jin,Yu Yuanyuan,Yue Hua,Zhang Zhenlin,Zhang Ge^ORCID

Publisher

Elsevier BV

Reference106 articles.

1. First missense mutation in the SOST gene causing sclerosteosis by loss of sclerostin function;Piters;Hum Mutat,2010

2. Localization of the gene for sclerosteosis to the van Buchem disease-gene region on chromosome 17q12-q21;Balemans;Am J Hum Genet,1999

3. PTH receptor signaling in osteocytes governs periosteal bone formation and intracortical remodeling;Rhee;J Bone Miner Res,2011

4. Sclerostin, an emerging therapeutic target for treating osteoporosis and osteoporotic fracture: a general review;Suen;J Orthop Translat,2016

5. Osteogenesis imperfecta: an update on clinical features and therapies;Marom;Eur J Endocrinol,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding pathophysiology and injury mechanisms is the foundation for invention/innovation and clinical translation in orthopaedics;Journal of Orthopaedic Translation;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP